Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage

The current global pandemic due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has taken a substantial number of lives across the world. Although few vaccines have been rolled-out, a number of vaccine candidates are still under clinical trials at various pharmaceutical companies and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Priyank, Pandey, Preeti, Prasad, Bodhayan, Robinson, Tony, Purohit, Rituraj, D’Cruz, Leon G, Tambuwala, Murtaza M, Mutreja, Ankur, Harkin, Jim, Rai, Taranjit Singh, Murray, Elaine K, Gibson, David S, Bjourson, Anthony J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769887/
https://www.ncbi.nlm.nih.gov/pubmed/34962259
http://dx.doi.org/10.1093/bib/bbab496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769887/
https://www.ncbi.nlm.nih.gov/pubmed/34962259
http://dx.doi.org/10.1093/bib/bbab496

Ejemplares similares